Return to homepagePandemic Pact

IMO4COV development of new immunomodulation molecules for prophylaxis and the treatment of serious covid-19 symptoms

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:1 publications

Grant number: FISR2020IP_04530

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $67,935.12

  • Funder

    Ministry of Education, University and Research Italy

  • Research Location

    Italy

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children.